Join the Cholesterol group to help and get support from people like you.
Cholesterol News
FDA Approves Juxtapid - New Orphan Drug for Rare Cholesterol Disorder
December 26, 2012 – On Dec. 21, the U.S. Food and Drug Administration approved Juxtapid (lomitapide) to reduce low-density lipoprotein (LDL) cholesterol, total cholesterol, apolipoprotein B, and...
Ask a question
To post your own question to this support group, sign in or create an account.